
Opinion|Videos|August 30, 2024
Future Considerations for Pneumococcal Vaccination
The key opinion leaders examine the recent approval of PCV21, assessing its potential influence on pneumococcal vaccination strategies, while also identifying and discussing current unmet needs in the field of pneumococcal vaccination.
Advertisement
Episodes in this series

- How will the recent approval of PCV21 impact pneumococcal vaccination decision making?
- What are the current unmet needs in the field of pneumococcal vaccination?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
3
FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5
















































































































































































































